8. Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S,
Sanmartin-Suarez C, Soto-Otero R. Autoxidation and MAO- -mediated metabolism of dopamine as a potential cause of
oxidative stress: role of ferrous and ferric ions. Neurochem Int
2004; 45: 103–116.
9. Johnson JR, Robinson BL, Ali SF, Binienda Z. Dopamine toxicity
following long term exposure to low doses of 3-nitropropionic
acid (3-NPA) in rats. Toxicol Lett 2000; 116: 113–118.
10. Li CL, Werner P, Cohen G. Lipid peroxidation in brain:
interactions of L-DOPA/dopamine with ascorbate and iron.
Neurodegeneration 1995; 4: 147–153.
11. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein
measurement with Folin fenol reagent. J Biol Chem 1951; 193:
265–275.
12. Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine
injections into the nigrostriatal pathway attenuate striatal
malonate and 3-nitropropionic acid lesions. Exp Neurol 1998;
154: 637–644.
13. Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. Mitochondrial
toxin inhibition of [(3)H]dopamine uptake into rat striatal
synaptosomes. Biochem Pharmacol 2002; 63: 1499–1505.
14. McLaughlin BA, Nelson D, Erecinska M, Chesselet MF. Toxicity of
dopamine to striatal neurons in vitro and potentiation of cell death
by a mitochondrial inhibitor. J Neurochem 1998; 70: 2406–2415.
15. Nishino H, Kumazaki M, Fukuda A, Fujimoto I, Shimano Y, Hida H,
Sakurai T, Deshpande SB, Shimizu H, Morikawa S, Inubushi T.
Acute 3-nitropropionic acid intoxication induces striatal astrocytic
cell death and dysfunction of the blood–brain barrier: involvement
of dopamine toxicity. Neurosci Res 1997; 27: 343–355.
16. Reynolds DS, Carter RJ, Morton AJ. Dopamine modulates the
susceptibility of striatal neurons to 3-nitropropionic acid in the rat
model of Huntington ́s disease. J Neurosci 1998; 18: 10116–10127.
17. Richter HW, Waddell WH. Mechanism of the oxidation of
dopamine by the hydroxyl radical in aqueous solution. J Am
Chem Soc 1983; 105: 5434–5440.
18. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D,
Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, et
al. Blockade of neuronal nitric oxide synthase protects against
excitotoxicity in vivo. J Neurosci 1995; 15: 8419–8429,
19. Slivka A, Cohen G. Hydroxyl radical attack on dopamine. J Biol
Chem 1985; 260: 15466–15472.
20. Spencer JP, Jenner A, Butler J, Aruoma OI, Dexter DT, Jenner P,
Halliwell B. Evaluation of the pro-oxidant and antioxidant
actions of L-DOPA and dopamine in vitro: implications for
Parkinson ́s disease. Free Radic Res 1996; 24: 95–105.
21. Sulkowski G, Dabrowska-Bouta B, Waskiewicz J, Rafalowska U.
Inhibition of dopamine transport and binding of [3H] spiperone
to dopamine D2 receptor by acute Pb-toxicity in vivo. Folia
Neuropathol 1999; 37: 205–209.
22. Yen GC, Hsieh CL. Antioxidant effects of dopamine and related
compounds. Biosci Biotechnol Biochem 1997; 61: 1646–1649.
23. Zeevalk GD, Derr-Yellin E, Nicklas WJ. NMDA receptor
involvement in toxicity to dopamine neurons in vitro caused by
the succinate dehydrogenase inhibitor 3-nitropropionic acid.
J Neurochem 1995; 64: 455–458.
